Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

9.33
Delayed Data
As of Jan 13
 +0.02 / +0.21%
Today’s Change
7.20
Today|||52-Week Range
16.80
-5.95%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close9.31
Today’s open9.31
Day’s range9.21 - 9.59
Volume277,786
Average volume (3 months)631,194
Market cap$400.4M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+16.43%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...+0.15+1.31%
FOMXFoamix Pharmaceutica...+0.27+2.60%
AVDLAvadel Pharmaceutica...-0.02-0.20%
MACKMerrimack Pharmaceut...-0.06-1.83%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs